Effects of psychotropics on driving performance

Sleep and Sleep Disorders: A Neuropsychopharmacological Approach

Volumn , Issue , 2006, Pages 146-150

  Moller, Henry J ^a   Shapiro, Colin M ^a   Kayumov, Leonid ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920044571     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27682-3_16     Document Type: Chapter

References (51)

1. Schweitzer PK. Drugs that disturb sleep and wakefulness. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd Ed. Saunders 2000:441-61.
2. Determining Medical Fitness to Drive: A Guide for Physicians (6th ed). 2000; Canadian Medical Association.
3. Tillman WA, Hobbs GE. The Accident-prone Automobile Driver, American J Psychiatry 1949; 321-331.
4. O'Neill D. Benzodiazepines and driver safety (editorial) Lancet. 1998; 352:1324-5.
5. Haigney D, Westerman SJ. Mobile (cellular) phone use and driving: A critical review of research methodology. Ergonomics 2001; 44:132-43.
6. Beeley L. Drugs and Medicines. In: Medical Aspects of fitness to drive: Medical commission on accident prevention. 4th ed. London: HMSO 1985:65-9.
7. McGwin G, Sims RV, Pulley L et al. Relations among chronic medical conditions, medications and automobile crashes in the elderly: A population-based case-control study. Am J Epidemiology 2000; 152:424-31.
8. Dodge M, Kitchin R. Introducing Cyberspace. In: Dodge, Kitchen, eds. Mapping Cyberspace. Roudedge, 2001.
9. Waterford JA, Waterford El. Presence and Absence in Educational VR: The Role of Perceptual Seduction in Conceptual Learning, Themes in Education. 2000; 1:7-38.
10. Chultheis M, Mourant R. Virtual reality and driving: The road to better assessment for cognitively impaired populations. Presence 2001; 10:431-9.
11. Moller H, Kayumov L, Shapiro CM. Microsleep Episodes, Attention Lapses and Circadian Variation in Psychomotor Performance in a Driving Simulation Paradigm. Proceedings of 2nd International Conference on Driving Assessment. Park City, Utah, 2003.
12. Home JA, Reyner LA Sleep-related vehicle accidents. BMJ 1995; 310:565-567.
13. Kecklund, Akerstedt. Time of day and Swedish road accidents. Shiftwork Int Newsletter 1995; 12:31.
14. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14:540-545.
15. Mider M, Carskaddon M, Hirschkowitz M. Daytime Tests. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd Ed. Saunders, 2000:1251-8.
16. Schmidt HS. Pupillometric assessment of disorders of arousal, Sleep. 1982; 5(Suppl 2):S157-S64.
17. Arnedt JT, Acebo C, Seifer R et al. Assessment of a Simulated Driving Task for Sleep Research. Sleep 24S 2001; A413.
18. Arnedt JT, Wilde GJ, Munt PW et al. Simulated driving performance following prolonged wakefulness and alcohol consumption: Separate and contributions to impairment. J Sleep Res 2000; 9:233-241.
19. George CF, Smiley A. Sleep apnea & automobile crashes. Sleep 1999; 22:790-5.
20. Moller H, Lowe A, Kayumov L et al. Can impaired alertness be detected more sensitively using a computerized driving simulator? Sleep 2002; A252-A253.
21. Powell NB, Schectman KB, Riley RW et al. The road to danger: comparative risks of driving while sleepy. Laryngoscope 2001; 111:887-93.
22. Lyznicki JM. Sleepiness, driving and motorvehicle crashes. JAMA 1998; 279:1908-13.
23. Dawson D, Reid K. Fatigue, alcohol and performance impairment. Nature 1997; 388:235.
24. Ramaekers JG, Robbe HW, O'Hanlon JF. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 2000; 7:551-558.
25. Lamers CT, Ramaekers JG. Visual search and urban driving under the influence of marijuana and alcohol. Hum Psychopharmacol 2001; 5:393-401.
26. Liguori A, Gatto CP, Jarrett DB. Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving. Psychopharmacology (Bed). 2002; 163:399-405.
27. Couper FJ, Pemberton M, Jarvis A et al. Prevalence of drug use in commercial traaor-trailer drivers. J Forensic Sci 2002; 47:562-7.
28. Caldwell JA, Caldwell JL. An in-flight investigation of the efficacy of dextroamphetamine for sustaining helicopter pilot performance. Aviat Space Environ Med 1997; 68:1073-80.
29. Mills KC, Spruill SE, Kaune RW et al. The influence of stimulants, sedatives and fatigue on tunnel vision: risk factors for driving and piloting. Hum Factors 2001; 43:310-27.
30. Logan BK, Couper FJ. 3, 4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving J Forensic Sci 2001; 46:1426-33.
31. Meltzer EO:Performance effects of antihistamines. J Allergy Clin Immunol 1990; 86:613-619.
32. Lisper HO, Tornos J, Van Loon J. Effects of caffeine or diazepam on subsidiary reaction time in a long term driving task. In: L Goldberg, ed. Alcohol Drugs and Traffic Safety. Stockholm: Almqvist &Wiksell: 1986:1024-1049.
33. Reyner LA, Home JA. Suppression of sleepiness in drivers: combination of caffeine with a short nap. Psychophysiology 1997; 34:721-72.
34. Hemmelgarn B, Suissa S, Huang A. Benzodiazepine use and the risk of motor-vehicle crash in the elderly. JAMA 1997; 278:27-31.
35. Vermeeren A, Riedel W, van Boxtel MP et al. Differential residual effects of zaleplon and zopiclone on actual driving: A comparison with low dose of alcohol. Sleep 2002; 25:224-31.
36. Linnoila M, Seppala T, Antidepressants and driving. Accid Anal & Prev 17 1985; 297-301.
37. Ramaekers JG. Antidepressants and driver impairment: Empirical Evidence from a standard on-the-road-test. J Clin Psychiatry 2003; 64:20-29.
38. Linnoila M, Seppala T, Mattila M et al. Clomipramine and doxepin in depressive neurosis. Arch Gen Psychiatry 1980; 37:1295-1299.
39. Hindmarch I. The behavioural toxicity of the selective serotonin reuptake inhibitors. Int Clin Psychopharmacol. 9 S 1995; 9(Suppl 4):13-7.
40. O'Hanlon JF, Freeman H. Categorizing the behavioural toxicities of antidepressants. B J Psychiaty 1995; 166:421-423.
41. Ridout F, Meadows R, Johnsen S et al. A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance. Hum Psychopharmacol. 2003; 18:261-9.
42. Kagerer S, Winter C, Moller HJ et al. Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study. Neuropsychobiology 2003; 47:212-8.
43. Robbe HW, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacology 1995; 5:35-42.
44. van Laar M, Willigenburg AP and Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacology 1994; 15:30-40.
45. Cox DJ, Merkel L, Kovatchev B et al. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder. J Nerv Mental Dis 2000; 188:230-234.
46. Hatcher S, Sims R, Thompson D The effects of chronic lithium treatment on psychomotor performance related to driving B J Psychiaty 1990; 157: 275-8.
47. Linnoila M, Saario I, Maki M. Effect of treatment with lithium and alcohol on psychomotor skills related to driving Eur J Clin Psychoparmacol 1974; 7:337-42.
48. Aldenlaunp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003; 44(Suppl 4):21-9.
49. Judd LL. The effect of antipsychotic drugs on driving and driving related psychomotor functions. Accid Anal Prev 1985; 17:319-22.
50. Frucht S, Rogers JD, Greene PE et al. Falling asleep at the wheel: Motor vehicle mishaps in people taking pramipexole and ropinorole. Neurology 1999; 52:1908-10.
51. Moller HJ. Antiparkinsonian Drugs and Sleep Attacks. CMAJ 2001; 164:1038-39.